NEUROPACE, INC. Increase (Decrease) in Accrued Liabilities
NEUROPACE, INC. (NPCE) reported Increase (Decrease) in Accrued Liabilities of -$2.49 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-11
- NEUROPACE, INC. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was $1.51M, a 31.95% decline year-over-year.
- NEUROPACE, INC. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$4.00M.
- NEUROPACE, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was $1.02M.
- NEUROPACE, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $2.65M, a 13.83% increase year-over-year.
- NEUROPACE, INC. increase (decrease) in accrued liabilities for fiscal 2025 was $3.55M.
- NEUROPACE, INC. increase (decrease) in accrued liabilities for fiscal 2024 was -$1.39M, a 136.94% decline from fiscal 2023.
- NEUROPACE, INC. increase (decrease) in accrued liabilities for fiscal 2023 was $3.77M.
- NEUROPACE, INC. increase (decrease) in accrued liabilities for fiscal 2022 was -$15.00K, a 100.87% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$2.49M 10-Q · filed 2026-08-11 | -$1.47M derived: sum of 3 quarters · filed 2026-08-11 | $1.18M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | -$4.00M 10-Q · filed 2026-05-12 | -$2.97M derived: sum of 2 quarters · filed 2026-05-12 | -$323.00K derived: sum of 3 quarters · filed 2026-05-12 | $1.89M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $3.67M derived: sum of 2 quarters · filed 2026-03-03 | $5.88M derived: sum of 3 quarters · filed 2026-08-11 | $3.55M 10-K · filed 2026-03-03 |
| 2025-09-30 | $2.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $4.86M derived: sum of 2 quarters · filed 2026-08-11 | $2.53M 10-Q · filed 2025-11-04 | $2.25M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $2.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$120.00K 10-Q · filed 2026-08-11 | -$404.00K derived: sum of 3 quarters · filed 2026-08-11 | $1.92M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | -$2.33M 10-Q · filed 2026-05-12 | -$2.62M derived: sum of 2 quarters · filed 2026-05-12 | -$289.00K derived: sum of 3 quarters · filed 2026-05-12 | $165.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | -$284.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $2.04M derived: sum of 2 quarters · filed 2026-03-03 | $2.50M derived: sum of 3 quarters · filed 2026-03-03 | -$1.39M 10-K · filed 2026-03-03 |
| 2024-09-30 | $2.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $2.78M derived: sum of 2 quarters · filed 2025-11-04 | -$1.11M 10-Q · filed 2025-11-04 | $37.00K derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $454.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$3.44M 10-Q · filed 2025-08-12 | -$2.29M derived: sum of 3 quarters · filed 2025-08-12 | -$437.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | -$3.89M 10-Q · filed 2025-05-13 | -$2.75M derived: sum of 2 quarters · filed 2025-05-13 | -$891.00K derived: sum of 3 quarters · filed 2025-05-13 | $712.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $3.00M derived: sum of 2 quarters · filed 2025-03-04 | $4.60M derived: sum of 3 quarters · filed 2025-03-04 | $3.77M 10-K · filed 2025-03-04 |
| 2023-09-30 | $1.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $3.46M derived: sum of 2 quarters · filed 2024-11-12 | $2.62M 10-Q · filed 2024-11-12 | $2.49M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $1.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $769.00K 10-Q · filed 2024-08-13 | $633.00K derived: sum of 3 quarters · filed 2024-08-13 | $1.22M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$834.00K 10-Q · filed 2024-05-08 | -$970.00K derived: sum of 2 quarters · filed 2024-05-08 | -$381.00K derived: sum of 3 quarters · filed 2024-05-08 | -$377.00K derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | -$136.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $453.00K derived: sum of 2 quarters · filed 2024-03-05 | $457.00K derived: sum of 3 quarters · filed 2024-03-05 | -$15.00K 10-K · filed 2024-03-05 |
| 2022-09-30 | $589.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $593.00K derived: sum of 2 quarters · filed 2023-11-06 | $121.00K 10-Q · filed 2023-11-06 | $544.00K derived: sum of 4 quarters · filed 2023-11-06 |
| 2022-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$468.00K 10-Q · filed 2023-08-08 | -$45.00K derived: sum of 3 quarters · filed 2023-08-08 | $730.00K derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | -$472.00K 10-Q · filed 2023-05-04 | -$49.00K derived: sum of 2 quarters · filed 2023-05-04 | $726.00K derived: sum of 3 quarters · filed 2023-05-04 | $2.34M derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $423.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $1.20M derived: sum of 2 quarters · filed 2023-03-02 | $2.81M derived: sum of 3 quarters · filed 2023-03-02 | $1.72M 10-K · filed 2023-03-02 |
| 2021-09-30 | $775.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $2.39M derived: sum of 2 quarters · filed 2022-11-08 | $1.30M 10-Q · filed 2022-11-08 | -$349.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $1.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $521.00K 10-Q · filed 2022-08-11 | -$1.12M derived: sum of 3 quarters · filed 2022-08-11 | $569.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | -$1.09M 10-Q · filed 2022-05-12 | -$2.74M derived: sum of 2 quarters · filed 2022-05-12 | -$1.05M derived: sum of 3 quarters · filed 2022-05-12 | -$114.00K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | -$1.65M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $48.00K derived: sum of 2 quarters · filed 2022-03-10 | $980.00K derived: sum of 3 quarters · filed 2022-03-10 | -$712.00K 10-K · filed 2022-03-10 |
| 2020-09-30 | $1.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $2.63M derived: sum of 2 quarters · filed 2021-11-10 | $933.00K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $932.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$760.00K 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | -$1.69M 10-Q · filed 2021-06-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |